Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “REGENERON PHARMACEUTICALS, INC.”

837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 837
Index total 30,257
Page 34 / 35

Quick answer

This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

837 results for “REGENERON PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 7119066

    Modified ciliary neurotrophic factor (CNTF)

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  2. US 7087411

    Fusion protein capable of binding VEGF

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 8, 2006 · Expires Aug 3, 2026

    granted
  3. US 7070959

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  4. US 7063840

    TIE-2 ligands, methods of making and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 20, 2006 · Expires Jun 15, 2026

    granted
  5. US 7052691

    Methods of treating diabetes by blocking VEGF-mediated activity

    REGENERON PHARMACEUTICALS, INC. · Granted May 30, 2006 · Expires May 25, 2026

    granted
  6. US 7052705

    Anti-angiogenic peptides

    REGENERON PHARMACEUTICALS, INC. · Granted May 30, 2006 · Expires May 25, 2026

    granted
  7. US 7052695

    Angiopoietins and methods of treating hypertension

    REGENERON PHARMACEUTICALS, INC. · Granted May 30, 2006 · Expires May 25, 2026

    granted
  8. US 7045302

    Expressed ligand-vascular intercellular signaling molecule

    REGENERON PHARMACEUTICALS, INC. · Granted May 16, 2006 · Expires May 11, 2026

    expired
  9. US 7008781

    Method of enhancing the biological activity of ligands

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 7, 2006 · Expires Mar 2, 2026

    expired
  10. US 6958140

    Methods of imaging and targeting vasculature

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 25, 2005 · Expires Oct 20, 2025

    expired
  11. US 6933276

    Methods of treating peripheral neuropathies using neurotrophin-3

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 23, 2005 · Expires Aug 18, 2025

    expired
  12. US 6927044

    IL-1 receptor based cytokine traps

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 9, 2005 · Expires Aug 4, 2025

    expired
  13. US 6881395

    TIE-2 ligand-4

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 19, 2005 · Expires Apr 14, 2025

    expired
  14. US 6852838

    Tyrosine kinase receptors and ligands

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 8, 2005 · Expires Feb 3, 2025

    expired
  15. US 6846914

    Tie-2 ligand-3

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 25, 2005 · Expires Jan 20, 2025

    expired
  16. US 6846908

    DCR-5 bone affecting ligand

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 25, 2005 · Expires Jan 20, 2025

    expired
  17. US 6833349

    Methods of treating inflammatory skin diseases

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 21, 2004 · Expires Dec 16, 2024

    expired
  18. US 6825008

    Expressed ligand—vascular intercellular signalling molecule

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 30, 2004 · Expires Nov 25, 2024

    expired
  19. US 6811780

    Methods of using cytokine antagonists to treat HIV infection and AIDS

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 2, 2004 · Expires Oct 28, 2024

    expired
  20. US 6767894

    Use of ciliary neurotrophic factor

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 27, 2004 · Expires Jul 22, 2024

    expired
  21. US 6680291

    Modified ciliary neurotrophic factor, method of making and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2004 · Expires Jan 15, 2024

    expired
  22. US 6660499

    DCR5, a BMP-binding protein, and applications thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 9, 2003 · Expires Dec 4, 2023

    expired
  23. US 6656474

    Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 2, 2003 · Expires Nov 27, 2023

    expired
  24. US 6645484

    Method of blocking blood vessel growth using tie-2 ligand 2

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 11, 2003 · Expires Nov 6, 2023

    expired